Chenqi Xu

21PUBLICATIONS
76CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityHaematological tumoursSensory processes, perception and performance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 05, 2026
HMGCS1 drives cholesterol-dependent membrane repair and shields tumor cells from lymphocyte attack.

|Mar 03, 2026
Harnessing lipid-driven immunometabolic pathways in omental metastases to enhance immunotherapy in patients with ovarian cancer.

Meggy Suarez-Carmona, Mareike Hampel, Xin-Wen Zhang

|Sep 10, 2025
Amplifying antigen-induced cellular responses with proximity labelling.

Shuojun Li, Yinghui Men, Zihan Wang

|Nov 11, 2024
Charge-based immunoreceptor signalling in health and disease.

Xiaoshan Shi, Xing He, Chenqi Xu

|Jul 11, 2024
The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling.

Yongjing Shi, Xiaodong Zheng, Hui Peng

|Jan 04, 2024
Shaping immune landscape of colorectal cancer by cholesterol metabolites.

Yibing Bai, Tongzhou Li, Qinshu Wang

Pageof 4

Frequent Collaborators

3 joint publications

Guangchuan Wang

2 joint publications

Xianmin Song

2 joint publications

Zhengjiang Zhu

2 joint publications

Haopeng Wang